Evidence map›Paper›PMID 10908254›Full record

ArticleHeart (British Cardiac Society)2000

Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993.

P Marques-Vidal, J B Ruidavets, J P Cambou, J Ferrières

Abstract read
In one paragraph

Article in Heart (British Cardiac Society), 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

P Marques-VidalDepartment of Epidemiology, INSERM U518, Faculté de Médecine Toulouse-Purpan, Toulouse cedex, France.
J B Ruidavets
J P Cambou
J Ferrières

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the impact of incidence, recurrence, and case fatality rates for myocardial infarction on coronary heart disease mortality in southwestern France between 1985 and 1993.

designToulouse-MONICA myocardial infarction register. SETTINGS AND PATIENTS: All subjects aged 35 to 64 years living in the French department of Haute-Garonne.

interventionsAll coronary artery disease events between 1985 and 1993.

main outcome measures7210 events collected by the register between 1985 and 1993.

resultsIn men, adjusted attack, total, and out of hospital mortality decreased by 2% (95% confidence interval (CI), -3.8% to -0.1%), 6.2% (95% CI -8.4% to -4.0%), and 4.2% (95% CI -7.0% to -1.5%) a year, respectively (p < 0.05). Incidence and recurrence rates decreased by 2% (95% CI -4.1% to -0.1%, p < 0.05) and 1.9% (95% CI -5.9% to 2.2%) a year (NS). In women, attack, total, and out of hospital mortality decreased by 1.7% (95% CI -5.2% to 1.8%), 4.8% (95% CI -9.6% to 0. 1%), and 2.6% (95% CI -9.4% to 4.1%) a year, respectively; incidence decreased by 2% (95% CI -6.5% to 2.5%) and recurrence increased by 1. 4% (95% CI -9.8% to 12.6%) a year (all NS). In men, total, incident, and recurrent 28 day case fatality decreased by 3.8% (95% CI -4.8% to -2.8%), 3.2% (95% CI -4.1% to -2.3%), and 6.4% (95% CI -9.5% to -3.3%) a year, respectively (p < 0.05). For women, the corresponding decreases were 3.3% (95% CI -6.1% to -0.6%), 3.3% (95% CI -13.2% to 6.6%), and 11.7% (95% CI -24.6% to 1.3%) a year, but only the decrease in total 28 day case fatality reached significance. In both sexes, the reduction in case fatality contributed nearly 70% of the decrease in myocardial infarction mortality.

conclusionsIn southwestern France, the decrease in myocardial infarction mortality mainly reflects improvements in acute management rather than prevention.

Indexed as

AdultFemaleFranceHumansIncidenceMaleMiddle AgedMyocardial InfarctionRecurrenceRegistriesRegression AnalysisSex DistributionSurvival Rate

Identifiers

PMID10908254
PMCPMC1760902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.